Tag: Prostate cancer

NAD+ precursor supplements promise anti-aging benefits, yet their effects on prostate cancer may be more complex than expected. While boosting NAD+ can support cellular wellness, research suggests it might also help cancer cells thrive. Get balanced insights from recent studies. keep reading

What if curing cancer meant strengthening your own immune defenses instead of relying on chemotherapy? With Anktiva, Dr. Patrick Soon-Shiong aims to arm the body’s natural killer cells in the fight against cancer, recently achieving FDA approval for bladder cancer and eyeing possibilities for prostate cancer and beyond. keep reading

Despite recent headlines, ibuprofen isn’t a proven shield against prostate cancer. While anti-inflammatory drugs have sparked scientific curiosity, current studies remain inconclusive on whether these over-the-counter meds actually lower prostate cancer risk. Instead, day-to-day habits like diet, exercise, and regular checkups still play a bigger role in staying healthy. keep reading

Curcumin, found in turmeric, is drawing scientific attention for its effects on prostate cancer, including inhibiting cancer cell growth. Despite promising lab results, making curcumin safe and effective for humans remains a challenge due to poor bioavailability. keep reading

Researchers are questioning if PSMA-PET scans, usually reserved for advanced prostate cancer, might offer added value when used alongside mpMRI earlier in diagnosis. Studies suggest a combined approach could improve detection, but questions remain about cost, accuracy, and future role. keep reading

What happens when prostate cancer questions collide with AI chatbots, social media, and the limits of technology? While online tools can supply fast answers, they can’t replicate the nuanced understanding between patient and physician. New research suggests online information should supplement, not replace, medical expertise. keep reading

Recent studies reveal the digital rectal exam may not improve early prostate cancer detection compared to PSA testing. As experts question its usefulness, advanced tools like multiparametric MRI are shaping modern screening guidelines. keep reading

Could a troubled heart and sluggish metabolism set the stage for more aggressive prostate cancer? Mounting studies reveal that cardiometabolic diseases like obesity, diabetes, and hypertension may actually fuel high-risk prostate cancer, but prevention and control are within reach for many men. keep reading

New research asks if healthy lifestyle choices—like diet, supplements, and exercise—can slow the growth of low-risk prostate cancer during active surveillance. While results remain inconclusive, promising signs exist, and minimally invasive focal therapy is emerging as an alternative option. keep reading